81 related articles for article (PubMed ID: 870353)
1. Hormonal and metabolic effects of somatostatin in diabetic patients submitted to an i.v. arginine infusion.
Assan R; Heuclin C; Girard JR; Basdevant A; Predine J; Husson JM
Diabete Metab; 1977 Mar; 3(1):11-7. PubMed ID: 870353
[TBL] [Abstract][Full Text] [Related]
2. Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.
Giugliano D; Luyckx AS; Lefebvre PJ
Diabete Metab; 1980 Mar; 6(1):39-46. PubMed ID: 6989660
[TBL] [Abstract][Full Text] [Related]
3. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
[TBL] [Abstract][Full Text] [Related]
4. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
Hansen AP; Christensen SE; Lundbaek K
Scand J Clin Lab Invest; 1975 May; 35(3):205-10. PubMed ID: 1153917
[TBL] [Abstract][Full Text] [Related]
5. Effect of ketone bodies on glucose production and utilization in the miniature pig.
Müller MJ; Paschen U; Seitz HJ
J Clin Invest; 1984 Jul; 74(1):249-61. PubMed ID: 6376544
[TBL] [Abstract][Full Text] [Related]
6. Pituitary and extrapituitary effects of somatostatin in normal man.
Copinschi G; Leclercq-Meyer V; Virasoro E; L'Hermite M; Vanhaelst L; Golstein J; Leclercq R; Féry F; Robyn C
Horm Metab Res; 1976 May; 8(3):226-31. PubMed ID: 181309
[TBL] [Abstract][Full Text] [Related]
7. Metabolic effects of adrenaline and noradrenaline in man: studies with somatostatin.
Pernet A; Walker M; Gill GV; Orskov H; Alberti KG; Johnston DG
Diabete Metab; 1984 May; 10(2):98-105. PubMed ID: 6146542
[TBL] [Abstract][Full Text] [Related]
8. Metabolic effects of graded glucagon infusions in man: inhibition of glucagon, insulin, and somatostatin response to arginine.
Pontiroli AE; Perfetti MG; Andreotti AC; Fattor B; Monti LD; Pozza G
Metabolism; 1993 Oct; 42(10):1242-8. PubMed ID: 8105365
[TBL] [Abstract][Full Text] [Related]
9. [Role of insulin and counter-regulatory hormones in the metabolic changes caused by insulin deprivation in diabetic patients].
Castillo MJ; Scheen AJ; Gualda P; Lefebvre PJ
Rev Esp Fisiol; 1989 Mar; 45(1):53-9. PubMed ID: 2664924
[TBL] [Abstract][Full Text] [Related]
10. Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon.
Gerich JE; Lorenzi M; Bier DM; Schneider V; Tsalikian E; Karam JH; Forsham PH
N Engl J Med; 1975 May; 292(19):985-9. PubMed ID: 804137
[TBL] [Abstract][Full Text] [Related]
11. Insulin-induced hypoglycemia is not aggravated by somatostatin in insulin-dependent diabetes.
Assan R; Heuclin C; Girard JR; Reach G; Basdevant A; Predine J
Diabete Metab; 1979 Sep; 5(3):189-94. PubMed ID: 499633
[No Abstract] [Full Text] [Related]
12. Effect of lipids on growth hormone secretion in humans.
Blackard WG; Hull EW; Lopez A
J Clin Invest; 1971 Jul; 50(7):1439-43. PubMed ID: 5090059
[TBL] [Abstract][Full Text] [Related]
13. Reduction of plasma leptin concentrations by arginine but not lipid infusion in humans.
Stingl H; Raffesberg W; Nowotny P; Waldhäusl W; Roden M
Obes Res; 2002 Nov; 10(11):1111-9. PubMed ID: 12429874
[TBL] [Abstract][Full Text] [Related]
14. The influence of plasma triglycerides on human growth hormone response to arginine and insulin: a study in hyperlipemics and normal subjects.
Muggeo M; Tiengo A; Fedele D; Crepaldi G
Horm Metab Res; 1975 Sep; 7(5):367-74. PubMed ID: 1183914
[TBL] [Abstract][Full Text] [Related]
15. The metabolic response to insulin deprivation in idiopathic brittle diabetes.
Husband DJ; Pernet A; Gill GV; Hanning I; Alberti KG
Diabetes Res; 1986 May; 3(4):193-8. PubMed ID: 3527516
[TBL] [Abstract][Full Text] [Related]
16. The role of insulin, glucagon and growth hormone in the regulation of plasma glucose and free fatty acid levels in anorexia nervosa.
Blickle JF; Reville P; Stephan F; Meyer P; Demangeat C; Sapin R
Horm Metab Res; 1984 Jul; 16(7):336-40. PubMed ID: 6386641
[TBL] [Abstract][Full Text] [Related]
17. Lack of beta-adrenergic role for catecholamines in the development of hyperglycemia and ketonaemia following acute insulin withdrawal in type I diabetic patients.
Beylot M; Sautot G; Dechaud H; Cohen R; Riou JP; Serusclat P; Mornex R
Diabete Metab; 1985 Apr; 11(2):111-7. PubMed ID: 2989015
[TBL] [Abstract][Full Text] [Related]
18. Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade.
Bjorkman O; Miles P; Wasserman D; Lickley L; Vranic M
J Clin Invest; 1988 Jun; 81(6):1759-67. PubMed ID: 3290252
[TBL] [Abstract][Full Text] [Related]
19. Effect of somatostatin on metabolic and hormonal changes induced by nicotinic acid in insulin-dependent diabetics.
Luyckx AS; Lefebvre PJ
Diabetologia; 1976 Oct; 12(5):447-53. PubMed ID: 976635
[TBL] [Abstract][Full Text] [Related]
20. The effects of somatostatin on hormonal and metabolic responses in chronic pancreatitis.
Botha JL; Vinik AI; le Roith D; Child PT; Jackson WP
S Afr Med J; 1977 Jun; 51(24):872-5. PubMed ID: 897837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
